顯示第 17 至 32 項結果,共 356 項
-
Anti-carcinoembryonic antigen (CEA) [Arcitumomab] (Ab00281-23.0-BT)
-
Anti-carcinoembryonic antigen (CEA) [Arcitumomab] (Ab00281-23.0)
-
Anti-CCL2 [CNTO 888 (Carlumab)] (Ab02245-23.0-BT)
-
Anti-CCL2 [CNTO 888 (Carlumab)] (Ab02245-23.0)
-
Anti-CCR4 [KW-0761 (Mogamulizumab)] (Ab00726-23.0-BT)
-
Anti-CCR4 [KW-0761 (Mogamulizumab)] (Ab00726-23.0)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-23.0-BT)
-
Anti-CD11a [hu1124 (Efalizumab)] (Ab00535-23.0)
-
Anti-CD134 [A10-F] (Ab02228-23.0-BT)
-
Anti-CD134 [A10-F] (Ab02228-23.0)
-
Anti-CD154 [IDEC-131 (Toralizumab)] (Ab01678-23.0-BT)
-
Anti-CD154 [IDEC-131 (Toralizumab)] (Ab01678-23.0)
-
Anti-CD166 [EJ212/007-C12-5] (Ab02669-23.0-BT)
-
Anti-CD166 [EJ212/007-C12-5] (Ab02669-23.0)
-
Anti-CD20 [10F381 (rituximab)] (Ab00126-23.0-BT)
-
Anti-CD20 [10F381 (rituximab)] (Ab00126-23.0)
